Literature DB >> 29135580

Wake me up before you go: a strategy to reduce the latent HIV reservoir.

Nicolas Chomont1,2, Afam A Okoye3,4, David Favre5, Lydie Trautmann6,7.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29135580      PMCID: PMC5758429          DOI: 10.1097/QAD.0000000000001695

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  63 in total

1.  A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.

Authors:  Adam M Spivak; Adriana Andrade; Evelyn Eisele; Rebecca Hoh; Peter Bacchetti; Namandjé N Bumpus; Fatemeh Emad; Robert Buckheit; Elinore F McCance-Katz; Jun Lai; Margene Kennedy; Geetanjali Chander; Robert F Siliciano; Janet D Siliciano; Steven G Deeks
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

2.  Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.

Authors:  Deirdre D Scripture-Adams; David G Brooks; Yael D Korin; Jerome A Zack
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.

Authors:  S A Kalams; P J Goulder; A K Shea; N G Jones; A K Trocha; G S Ogg; B D Walker
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy.

Authors:  Emily K Cartwright; Lori Spicer; S Abigail Smith; David Lee; Randy Fast; Sara Paganini; Benton O Lawson; Melon Nega; Kirk Easley; Joern E Schmitz; Steven E Bosinger; Mirko Paiardini; Ann Chahroudi; Thomas H Vanderford; Jacob D Estes; Jeffrey D Lifson; Cynthia A Derdeyn; Guido Silvestri
Journal:  Immunity       Date:  2016-09-20       Impact factor: 31.745

5.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

6.  Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.

Authors:  Line Vibholm; Mariane H Schleimann; Jesper F Højen; Thomas Benfield; Rasmus Offersen; Katrine Rasmussen; Rikke Olesen; Anders Dige; Jørgen Agnholt; Judith Grau; Maria Buzon; Burghardt Wittig; Mathias Lichterfeld; Andreas Munk Petersen; Xutao Deng; Mohamed Abdel-Mohsen; Satish K Pillai; Sofie Rutsaert; Wim Trypsteen; Ward De Spiegelaere; Linos Vandekerchove; Lars Østergaard; Thomas A Rasmussen; Paul W Denton; Martin Tolstrup; Ole S Søgaard
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

7.  A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.

Authors:  Francesco Andrea Procopio; Rémi Fromentin; Deanna A Kulpa; Jessica H Brehm; Anne-Gaelle Bebin; Matthew C Strain; Douglas D Richman; Una O'Doherty; Sarah Palmer; Frederick M Hecht; Rebecca Hoh; Richard J O Barnard; Michael D Miller; Daria J Hazuda; Steven G Deeks; Rafick-Pierre Sékaly; Nicolas Chomont
Journal:  EBioMedicine       Date:  2015-06-27       Impact factor: 8.143

8.  High production rates sustain in vivo levels of PD-1high simian immunodeficiency virus-specific CD8 T cells in the face of rapid clearance.

Authors:  Constantinos Petrovas; Takuya Yamamoto; David A Price; Srinivas S Rao; Nichole R Klatt; Jason M Brenchley; Daniel C Douek; Emma Gostick; Bastian R Angermann; Zvi Grossman; Derek C Macallan; Martin Meier-Schellersheim; Richard A Koup
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

9.  Immune clearance of highly pathogenic SIV infection.

Authors:  Scott G Hansen; Michael Piatak; Abigail B Ventura; Colette M Hughes; Roxanne M Gilbride; Julia C Ford; Kelli Oswald; Rebecca Shoemaker; Yuan Li; Matthew S Lewis; Awbrey N Gilliam; Guangwu Xu; Nathan Whizin; Benjamin J Burwitz; Shannon L Planer; John M Turner; Alfred W Legasse; Michael K Axthelm; Jay A Nelson; Klaus Früh; Jonah B Sacha; Jacob D Estes; Brandon F Keele; Paul T Edlefsen; Jeffrey D Lifson; Louis J Picker
Journal:  Nature       Date:  2013-09-11       Impact factor: 49.962

10.  Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes.

Authors:  Richard Brad Jones; Rachel O'Connor; Stefanie Mueller; Maria Foley; Gregory L Szeto; Dan Karel; Mathias Lichterfeld; Colin Kovacs; Mario A Ostrowski; Alicja Trocha; Darrell J Irvine; Bruce D Walker
Journal:  PLoS Pathog       Date:  2014-08-14       Impact factor: 6.823

View more
  4 in total

1.  Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12-15 December 2017, Miami, FL, USA.

Authors:  Christina K Psomas; Alain Lafeuillade; David Margolis; Karl Salzwedel; Mario Stevenson; Nicolas Chomont; Guido Poli; Jean-Pierre Routy
Journal:  J Virus Erad       Date:  2018-04-01

Review 2.  CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy.

Authors:  Federico Perdomo-Celis; Natalia A Taborda; Maria T Rugeles
Journal:  Front Immunol       Date:  2019-08-09       Impact factor: 7.561

Review 3.  Measuring the Success of HIV-1 Cure Strategies.

Authors:  Jordan Thomas; Alessandra Ruggiero; William A Paxton; Georgios Pollakis
Journal:  Front Cell Infect Microbiol       Date:  2020-04-07       Impact factor: 5.293

Review 4.  Pathways towards human immunodeficiency virus elimination.

Authors:  Prasanta K Dash; Bhavesh D Kevadiya; Hang Su; Mary G Banoub; Howard E Gendelman
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.